Peruvian researchers develop vaccine to fight acute pneumonia in alpacas

By: Andina
Photo: Courtesy of Andina

Original content from Andina.

A group of researchers from Lima-based San Marcos National University developed a vaccine to prevent and control acute Pasteurella multocida pneumonia in young and baby alpacas.

The project was co-financed by Peru's Production Ministry through its Innovate Peru Program.

"The study constitutes an important contribution to acute pneumonia treatment in South American camelids since there is no research on a specific vaccine to combat the effects of this disease in alpacas to date," Research Project Coordinator Abelardo Lenin Maturrano Hernandez stated.

According to him, this ailment is the leading cause of death among young alpacas and the second most common among neonates.

Developed with the use of reverse vaccinology techniques, this recombinant vaccine (recombinant protein) is intended to bolster alpacas' defenses against bacterial pathogens causing the respiratory illness.

Read the rest of this story and view the photos at Andina.